Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors High levels of DNA replication stress and defects in the ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...

Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC. The panel discussion focused on the ...

Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...

If we were to convene a panel of healthcare experts to choose a goal that holds the promise of being both achievable and influential at improving the value of healthcare, it may very well be the ...

The 10-year anniversary meeting, November 10-11 in Boston, returns to CPC’s roots—uniting decision-makers on execution, evidence, and sustainable care delivery. CPC returns to its roots this year as a ...

Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...

Plasmalogen precursors for Alzheimer’s are named as first program candidate There are nutrients and dietary compounds ...